According to a newly published market research report by 24LifeSciences, global head and neck cancer diagnostics market was valued at USD 1.85 billion in 2024 and is projected to reach USD 3.47 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.1% during the forecast period 20252032. Head and neck cancer diagnostics encompass a sophisticated array of imaging...

Liquid biopsy has emerged as one of the most promising innovations in modern diagnostics, offering a minimally invasive approach to detect, monitor, and manage various diseases, particularly cancer. Unlike traditional tissue biopsies, liquid biopsy analyzes biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and other molecular components present in body...

According to a newly published market research report by 24LifeSciences, the global thyroid cancer testing market was valued at USD 1.63 billion in 2024 and is projected to reach USD 2.84 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2031. Thyroid cancer testing encompasses a comprehensive suite of diagnostic procedures essential...